Constipation Drug Induced
10
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
20%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Effectiveness of Self-Administered Acupressure Intervention in Managing Constipation of Adult Psychiatric In-Patient
Effectiveness of Self-administered Acupressure Intervention in Managing Constipation of Adult Psychiatric Out-patient
Prevention of Constipation in Cancer Patients
Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation
Naloxegol and Opioid-induced Constipation
Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol
Constipation Bundle/Protocol and the Effect of Adherence in the Incidence of Constipation in Critically Ill Patients
The Efficacy of Acupressure in Managing Opioid-induced Constipation
Effect of Naloxegol on Gastric, Small Bowel, and Colonic Transit in Healthy Subjects
Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery